Skip to main content

Advertisement

SpringerLink
Log in

Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts

  • Report
  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Alpinia galanga has been used as alternative medicine for anti-rheumatic activities. However, the precise action of the extract on arthritic diseases is not yet fully understood. In this study, we investigated the effects of A. galanga extracts on the expression of genes involved in catabolic activities in an interleukin-1β (IL-1β)-induced human synovial fibroblast as an inflammatory model. Confluent primary human synovial fibroblasts were treated for 24 h with A. galanga hexane extracts in the presence of recombinant human IL-1β. MMPs in the culture medium were monitored by gelatin zymography. Total RNA was isolated from the cell lysate and analyzed via semi-quantitative RT-PCR. After treatment with A. galanga extracts, MMP-2 activity in the culture medium was significantly reduced. In addition, MMP-1, MMP-3, MMP-13, and Cox-2 expression were downregulated. These data suggest that the decrease of gene expression and production of MMPs in synovial fibroblasts against inflammatory stimuli could be due to the effects of the A. galanga extracts. Therefore, A. galanga extracts might be a promising therapeutic agent for arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.
Figure 2.
Figure 3.

Similar content being viewed by others

References

  • Ahrens D.; Koch A. E.; Pope R. M.; Stein-Picarella M.; Niedbala M. J. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 39: 1576–87; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Arend W. P.; Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33: 305–15; 1990.

    Article  PubMed  CAS  Google Scholar 

  • Chakraborti S.; Mandal M.; Das S.; Mandal A.; Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253: 269–85; 2003.

    Article  PubMed  CAS  Google Scholar 

  • Chikanza I. C.; Kingsley G.; Panayi G. S. Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J. Rheumatol. 22: 600–6; 1995.

    PubMed  CAS  Google Scholar 

  • Davis L. S. A question of transformation: the synovial fibroblast in rheumatoid arthritis. Am. J. Pathol. 162: 1399–402; 2003.

    Article  PubMed  Google Scholar 

  • Dayer J. M.; Feige U.; Edwards 3 rd C. K.; Burger D. Anti-interleukin-1 therapy in rheumatic diseases. Curr. Opin. Rheumatol. 13: 170–6; 2001.

    Article  PubMed  CAS  Google Scholar 

  • Egeblad M.; Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2: 161–74; 2002.

    Article  PubMed  CAS  Google Scholar 

  • Firestein G. S. Evolving concepts of rheumatoid arthritis. Nature 423: 356–61; 2003.

    Article  PubMed  CAS  Google Scholar 

  • Gaudin P.; Razakaboay M.; Surla A.; Berthier S.; Fauconnier J.; Morel F.; Phelip X. A study of metalloproteinases in fifty joint fluid specimens. Rev. Rhum. Engl. Ed. 64: 375–81; 1997.

    PubMed  CAS  Google Scholar 

  • Gilroy D. W.; Tomlinson A.; Willoughby D. A. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm. Res. 47: 79–85; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Gruber B. L.; Sorbi D.; French D. L.; Marchese M. J.; Nuovo G. J.; Kew R. R.; Arbeit L. A. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin. Immunol. Immunopathol. 78: 161–71; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Grzanna R.; Lindmark L.; Frondoza C. G. Ginger–an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food 8: 125–32; 2005.

    Article  PubMed  CAS  Google Scholar 

  • Houssiau F. A. Cytokines in rheumatoid arthritis. Clin. Rheumatol. 14(Suppl 2): 10–3; 1995.

    Article  PubMed  Google Scholar 

  • Ishiguro N.; Ito T.; Miyazaki K.; Iwata H. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis. J. Rheumatol. 26: 34–40; 1999.

    PubMed  CAS  Google Scholar 

  • Ishiguro N.; Ito T.; Obata K.; Fujimoto N.; Iwata H. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J. Rheumatol. 23: 1599–604; 1996.

    PubMed  CAS  Google Scholar 

  • Jackson C.; Nguyen M.; Arkell J.; Sambrook P. Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis–targetting gelatinase A activation. Inflamm. Res. 50: 183–6; 2001.

    Article  PubMed  CAS  Google Scholar 

  • Konttinen Y. T.; Ainola M.; Valleala H.; Ma J.; Ida H.; Mandelin J.; Kinne R.; Santavirta S.; Sorsa T.; Lopez-Otin C.; Takagi M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 58: 691–7; 1999.

    Article  PubMed  CAS  Google Scholar 

  • Konttinen Y. T.; Ceponis A.; Takagi M.; Ainola M.; Sorsa T.; Sutinen M.; Salo T.; Ma J.; Santavirta S.; Seiki M. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol. 17: 585–601; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Lee D. M.; Weinblatt M. E. Rheumatoid arthritis. Lancet 358: 903–11; 2001.

    Article  PubMed  CAS  Google Scholar 

  • Lindy O.; Konttinen Y. T.; Sorsa T.; Ding Y.; Santavirta S.; Ceponis A.; Lopez-Otin C. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 40: 1391–9; 1997.

    Article  PubMed  CAS  Google Scholar 

  • Lipsky P. E. Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed? J. Rheumatol. Suppl. 56: 25–30; 1999.

    PubMed  CAS  Google Scholar 

  • Lluri G.; Jaworski D. M. Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation. Muscle Nerve 32: 492–9; 2005.

    Article  PubMed  CAS  Google Scholar 

  • Matsuda H.; Pongpiriyadacha Y.; Morikawa T.; Ochi M.; Yoshikawa M. Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: structural requirements and mode of action. Eur. J. Pharmacol. 471: 59–67; 2003.

    Article  PubMed  CAS  Google Scholar 

  • Moore B. A.; Aznavoorian S.; Engler J. A.; Windsor L. J. Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim. Biophys. Acta 1502: 307–18; 2000.

    PubMed  CAS  Google Scholar 

  • Muller-Ladner U.; Kriegsmann J. Franklin BN.; Matsumoto S.; Geiler T.; Gay RE, Gay S. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149: 1607–15; 1996.

    PubMed  CAS  Google Scholar 

  • Murphy G.; Crabbe T. Gelatinases A and B. Meth. Enzymol. 248: 470–84; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Ollivierre F.; Gubler U.; Towle C. A.; Laurencin C.; Treadwell B. V. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. Biochem. Biophys. Res. Commun. 141: 904–11; 1986.

    Article  PubMed  CAS  Google Scholar 

  • Pelletier J. P.; McCollum R.; Cloutier J. M.; Martel-Pelletier J. Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J. Rheumatol. Suppl. 43: 109–14; 1995.

    PubMed  CAS  Google Scholar 

  • Petrow P. K.; Wernicke D.; Schulze W. C.; Hummel K. M.; Brauer R.; Kriegsmann J.; Gromnica-Ihle E.; Gay R. E.; Gay S. Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Ann. Rheum. Dis. 61: 391–7; 2002.

    Article  PubMed  CAS  Google Scholar 

  • Pope R. M. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat. Rev. Immunol. 2: 527–35; 2002.

    Article  PubMed  CAS  Google Scholar 

  • Pothacharoen P.; Choocheep K.; Phitak T.; Poompimon W.; Premanod B.; Hardingham T. E.; Kongtawelert P. Effect of Alpinia galanga extract on cartilage degradation and on gene epression in human chondrocyte and synovial fibroblast metabolism. Cent. Eur. J. Biology. 3: 430–450; 2006.

    Article  Google Scholar 

  • Ritchlin C. Effector signals released by the synovial fibroblast in arthritis. Fibroblast biology. Arthritis Res. 2: 356–60; 2000.

    Article  PubMed  CAS  Google Scholar 

  • Saxne T.; Palladino Jr. M. A.; Heinegard D.; Talal N.; Wollheim F. A. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31: 1041–5; 1988.

    Article  PubMed  CAS  Google Scholar 

  • Scott B. B.; Weisbrot L. M.; Greenwood J. D.; Bogoch E. R.; Paige C. J.; Keystone E. C. Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation. Arthritis Rheum. 40: 490–8; 1997.

    Article  PubMed  CAS  Google Scholar 

  • Shinmei M.; Masuda K.; Kikuchi T.; Shimomura Y. Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Semin. Arthritis Rheum. 18: 27–32; 1989.

    Article  PubMed  CAS  Google Scholar 

  • Sopata I.; Wize J.; Filipowicz-Sosnowska A.; Stanislawska-Biernat E.; Brzezinska B.; Maslinski S. Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases. Rheumatol. Int. 15: 9–14; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Vincenti M. P.; Clark I. M.; Brinckerhoff C. E. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 37: 1115–26; 1994.

    Article  PubMed  CAS  Google Scholar 

  • Walsh D. A. Angiogenesis and arthritis. Rheumatology (Oxford) 38: 103–12; 1999.

    Article  CAS  Google Scholar 

  • Westhoff C. S.; Freudiger D.; Petrow P.; Seyfert C.; Zacher J.; Kriegsmann J.; Pap T.; Gay S.; Stiehl P.; Gromnica-Ihle E.; Wernicke D. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum. 42: 1517–27; 1999.

    Article  PubMed  CAS  Google Scholar 

  • Yamanishi Y.; Firestein G. S. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum. Dis. Clin. North Am. 27: 355–71; 2001.

    Article  PubMed  CAS  Google Scholar 

  • Yoshihara Y.; Nakamura H.; Obata K.; Yamada H.; Hayakawa T.; Fujikawa K.; Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59: 455–61; 2000.

    Article  PubMed  CAS  Google Scholar 

  • Zucker S.; Lysik R. M.; Zarrabi M. H.; Greenwald R. A.; Gruber B.; Tickle S. P.; Baker T. S.; Docherty A. J. Elevated plasma stromelysin levels in arthritis. J. Rheumatol. 21: 2329–33; 1994.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The Thailand Research Fund (TRF Basic Research Scholar to PK), The Royal Golden Jubilee Ph.D. Program, (Grant No. PHD/0121/2547 to KC: Grant No. PHD/0155/2548 to TP) and the National Research Council of Thailand (Research Program of Drug, Chemical, Medical Material and Equipment) jointly funded this work.

Author information

Authors and Affiliations

  1. Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand

    Peraphan Pothacharoen, Kanyamas Choocheep, Thanyaluck Phitak & Prachya Kongtawelert

  2. Faculty of Science, Lampang Rajabhat University, Lampang, Thailand

    Wilart Pompimon

Authors
  1. Peraphan Pothacharoen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kanyamas Choocheep
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thanyaluck Phitak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wilart Pompimon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prachya Kongtawelert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prachya Kongtawelert.

Additional information

Editor: J. Denry Sato

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pothacharoen, P., Choocheep, K., Phitak, T. et al. Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts. In Vitro Cell.Dev.Biol.-Animal 47, 183–187 (2011). https://doi.org/10.1007/s11626-010-9375-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-010-9375-2

Keywords

Search

Navigation